Delivery Order SPE2DB22D3016-SPE2DB24FBCN5

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,156,005 units of Modafinil 100 mg tablets, a medication used to treat conditions such as narcolepsy and sleep apnea. The contract has a firm fixed price of $3,728.99 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,005.94, is for the provision of 4,567,964,093 tablets of 100 mg modafinil, a medication used to treat sleep disorders. The contract has an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $2,231.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,617,647 tablets of the medication modafinil 100 mg, with a period of performance through June 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award, valued at $11,338.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of modafinil 100 mg tablets, a prescription medication used to treat sleep disorders. The award is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,133,556 tablets of 100 mg modafinil, a medication used to treat sleep disorders. The contract has a ceiling value of $4,160.93 and a period of performance through May 6, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,631,288 units of Modafinil 200 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $1,172.90 and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,909,870 units of Modafinil 100 mg tablets, a medication used to treat various conditions. The contract has a ceiling value of $6,460.02 and runs through April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,035.96, is for the supply of 4,565,218,326 units of Modafinil 200 mg tablets in 30-count packages. The contract has a firm fixed price and an ultimate completion date of July 23, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,345.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,146,042 units of the prescription medication Modafinil 100 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, which has a ceiling value of $999,999,999.00. This IDC provides a...
This federal contract award is for the delivery of 4,567,692,794 units of modafinil 100 mg tablets in 30-count packages. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a firm fixed price of $4,089.00 and a completion date of March 26, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBCN5
    Delivery Order

This is a $1,168.29 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,297,215 units of 200 mg modafinil tablets, a medication used to treat sleep disorders. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation and is scheduled for completion by July 31, 2024.

Generated 10/29/24, 9:08 AM